Overview

Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant

Status:
Unknown status

Trial end date:
2005-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and efficacy of risperidone augmentation in patients who have failed to respond or only partially responded to an adequate trial of an antidepressant.

Phase:

Phase 3

Details

Lead Sponsor:

Rhode Island Hospital

Collaborators:

Emory University
Janssen Pharmaceutica N.V., Belgium

Treatments:

Antidepressive Agents
Risperidone